Fairfax Financial (OTCMKTS:FRFHF – Get Free Report) had its price target hoisted by stock analysts at Royal Bank of Canada from $1,425.00 to $1,500.00 in a research report issued on Monday, Benzinga reports. The firm currently has an “outperform” rating on the financial services provider’s stock. Royal Bank of Canada’s price target suggests a potential upside of 11.11% from the stock’s previous close.
Fairfax Financial Stock Performance
Shares of OTCMKTS FRFHF traded up $104.48 during trading hours on Monday, reaching $1,350.00. The stock had a trading volume of 7,200 shares, compared to its average volume of 6,030. The firm has a 50-day moving average of $1,240.40 and a 200-day moving average of $1,166.88. The company has a current ratio of 4.09, a quick ratio of 4.09 and a debt-to-equity ratio of 0.42. Fairfax Financial has a fifty-two week low of $838.11 and a fifty-two week high of $1,350.00. The firm has a market cap of $31.35 billion, a price-to-earnings ratio of 8.26 and a beta of 0.79.
Fairfax Financial (OTCMKTS:FRFHF – Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The financial services provider reported $37.18 earnings per share for the quarter. The business had revenue of $7.49 billion during the quarter. Fairfax Financial had a net margin of 13.40% and a return on equity of 15.37%. Equities research analysts predict that Fairfax Financial will post 149.57 earnings per share for the current year.
Fairfax Financial Company Profile
Fairfax Financial Holdings Limited, through its subsidiaries, provides property and casualty insurance and reinsurance, and investment management services in the United States, Canada, Asia, and internationally. The company operates through Property and Casualty Insurance and Reinsurance, Life insurance and Run-off, and Non-Insurance Companies segments.
Recommended Stories
- Five stocks we like better than Fairfax Financial
- What are earnings reports?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How Technical Indicators Can Help You Find Oversold StocksÂ
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
- What Are Dividend Challengers?
- 3 Stocks That Are Potential Takeover Targets in 2025
Receive News & Ratings for Fairfax Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fairfax Financial and related companies with MarketBeat.com's FREE daily email newsletter.